{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2019-05-21&answer.dateOfAnswer=2019-07-08&min-answer.questionFirstAnswered.=2019-07-08T15%3A42%3A06.313Z&max-date=2019-07-01", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-date=2019-05-21&answer.dateOfAnswer=2019-07-08&min-answer.questionFirstAnswered.=2019-07-08T15%3A42%3A06.313Z&max-date=2019-07-01", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2019-05-21&answer.dateOfAnswer=2019-07-08&min-answer.questionFirstAnswered.=2019-07-08T15%3A42%3A06.313Z&max-date=2019-07-01&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-date=2019-05-21&answer.dateOfAnswer=2019-07-08&min-answer.questionFirstAnswered.=2019-07-08T15%3A42%3A06.313Z&max-date=2019-07-01", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2019-05-21&answer.dateOfAnswer=2019-07-08&min-answer.questionFirstAnswered.=2019-07-08T15%3A42%3A06.313Z&max-date=2019-07-01", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2019-05-21&answer.dateOfAnswer=2019-07-08&min-answer.questionFirstAnswered.=2019-07-08T15%3A42%3A06.313Z&max-date=2019-07-01", "items" : [{"_about" : "http://data.parliament.uk/resources/1135744", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135744/answer", "answerText" : {"_value" : "

Adverse events are reported to the Medicines and Healthcare products Regulatory Agency (MHRA) using the Yellow card scheme and can be undertaken by a healthcare professional or the individual experiencing the adverse effect. The demographics required by the Yellow card scheme do not include the occupation of the subject, so military personnel are not uniquely identified.<\/p>

The aims of the "713/MoDREC/15" study do not include assessing whether individuals or their healthcare professional reported side effects to the MHRA or to follow-up whether any person experiencing side effects required any form of treatment, including an assessment of whether suitable treatment was available. Data collated in the study is self-reported by individuals and any symptoms reported may not necessarily be related to the anti-malarial taken.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"} } , "answeringMemberPrinted" : {"_value" : "Earl Howe"} , "dateOfAnswer" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-08T16:39:39.247Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2019-07-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Malaria: Drugs"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government whether the health and wellbeing of all participants in the Surgeon-General\u2019s 2016\u201317 research study on anti-malarial chemoprophylaxis (Ref: 713/MoDREC/15) was monitored to ensure that all adverse events occurring during the study were reported to the Medicines and Healthcare products Regulatory Agency (MHRA); whether participants have been monitored following the study to ensure that any adverse events that have occurred since are being reported to the MHRA; and what assessment they have made of whether suitable treatment is available to those participants suffering adverse events.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"} } , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"} ], "uin" : "HL16837"} , {"_about" : "http://data.parliament.uk/resources/1135772", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135772/answer", "answerText" : {"_value" : "

The government remains committed to continuing to support all carers to provide care as they would wish in a way that supports their own health, wellbeing and life chances. In June 2018, the Department of Health and Social Care (DHSC) published the Carers Action Plan, a cross-government programme of targeted work to support all carers, including young carers.<\/p>

<\/p>

DHSC has been working with The Children\u2019s Society to identify and publicise effective practices to local authorities to support young adult carers to make positives transitions between the ages of 16-24. To this end, \u2018Shaping our Future: Improving Assessment and Support for Young Carers\u2019 Transition to Adulthood\u2019 was published in June 2019.<\/p>

<\/p>

Further to the reply to PQ 237696<\/a>, the government is clear that the Care Act (2014) does place duties on local authorities to undertake transition assessments, and that Care and Support Statutory Guidance sets out how these duties should be met.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-08T16:13:38.1Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2019-07-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Young People: Carers"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Education, what steps he is taking to ensure that local authorities fulfil their statutory duties under section 63 of the Care Act 2014 to provide transition assessments for young carers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"} } , "tablingMemberConstituency" : {"_value" : "Bristol West"} , "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"} ], "uin" : "271454"} , {"_about" : "http://data.parliament.uk/resources/1135897", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135897/answer", "answerText" : {"_value" : "

The Budget 2016 announced funding for a number of programmes linked to the revenue from the Soft Drinks Industry Levy (SDIL). The Department for Education will receive £575 million during the current Spending Review period.<\/p>

The funding has been used for the following projects:<\/p>